Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Consolidated Net Income (2016 - 2026)

Ekso Bionics Holdings has reported Consolidated Net Income over the past 14 years, most recently at -$4.7 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 103.76% to -$4.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$13.6 million, a 27.09% decrease, with the full-year FY2025 number at -$13.6 million, down 27.09% from a year prior.
  • Consolidated Net Income reached -$4.7 million in Q4 2025 per EKSO's latest filing, down from -$1.4 million in the prior quarter.
  • The five-year high for Consolidated Net Income was -$1.4 million in Q3 2025, with the low at -$4.7 million in Q4 2025.
  • The 5-year median for Consolidated Net Income is -$3.4 million (2021), against an average of -$3.5 million.
  • The largest YoY upside for Consolidated Net Income was 47.76% in 2025 against a maximum downside of 103.76% in 2025.
  • Tracing EKSO's Consolidated Net Income over 5 years: stood at -$4.6 million in 2021, then grew by 1.87% to -$4.5 million in 2022, then increased by 21.92% to -$3.5 million in 2023, then surged by 34.88% to -$2.3 million in 2024, then plummeted by 103.76% to -$4.7 million in 2025.
  • According to Business Quant data, Consolidated Net Income over the past three periods came in at -$4.7 million, -$1.4 million, and -$4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.